‹ BackHN Continuity

Thread

Claude discovers a novel enzyme system with CRISPR-like repeats

780 points · 805 comments · raahelb

  1. modeless · · focus · HN ↗
    It's clear Dario believes that the solution to AI's PR problem is to cure cancer. Or invent other revolutionary medical treatments. They're going to heavily promote every step along the way no matter how small or far away from commercialization they are, like this one.

    No doubt that curing cancer would help, but I think the timeline might be a little too long. Even RSI AGI will not be able to get new medical treatments to market instantly. Real world testing takes a long time and is an unavoidable part of the process.

    1. segmondy · · focus · HN ↗
      You can't say this. We have no idea. There is nothing about the law of physics that pushes cancer cure a long time away. A lot of people would have told you AI was decades away, yet here we are. We are still on track for possible strong take off.

      Now on real world testing, you think the rule applies? I tell you it doesn't. Human life might be precious, but human life in practice is also not precious. We waste so much of it. In some countries regulations will stop/slow it, but there are plenty of places around the world that will turn a blind eye for a fistful of dollars. Countries will go to those locations if it means gaining an edge.

      1. SpicyLemonZest · · focus · HN ↗
        There's a lot about biology that makes cancer fundamentally hard to treat, and the efficacy of cancer treatments fundamentally hard to measure. I'm optimistic that we'll eventually get to a point where we can meaningfully say we "cured cancer", but it will almost certainly be a cluster of thousands of treatment protocols which each have to be tested over 5-10 years for recurrence. There's no reason to expect that there should exist any broad-spectrum cancer treatment better than radiotherapy, or any fast test to determine whether long-term remission will be achieved.
Open on Hacker News to reply ↗

Unofficial Hacker News client; not affiliated with Y Combinator.